News | November 18, 2024
Richard Manning provided trial testimony that contributed to a decisive legal victory for biotech startup Inhibrx in a $460 million trade secrets case brought by I-Mab Biopharma in Delaware federal district court.
Trademarks are often an essential component of a company’s business model and plan. Trademarks, a form of intellectual property, are symbols, logos, words, or designs that assign unique identifiers to goods or services so consumers can identify a particular company’s offerings and distinguish them from competing offerings. Various remedies are available in trademark litigation, including actual damages, the defendant’s profits, statutory damages, reasonable royalty damages, and injunctive relief. Our economic, finance, accounting, and statistical experts provide robust research, analysis, and expertise to assist clients in resolving Lanham Act and other trademark disputes involving claims for monetary recovery or injunctive relief.
Determining and quantifying an appropriate remedy or remedies in trademark litigation can involve challenging economic issues including an analysis of causation (i.e., a nexus, or economic link, between the alleged conduct and economic performance), evaluation of factors that affect financial outcomes and that are unrelated to the alleged conduct, determination of the length of the loss period, identification and measurement of offsets to claimed damages, and assessment of possible future damages. Resolving these issues may involve addressing the competitive relationship, or lack thereof, between the relevant products or companies and evaluating the impact of alleged conduct on consumer impressions.
Our analyses of trademark issues are not cookie-cutter; instead, we tailor our approaches to the specific issues of each case, letting relevant facts and robust analytical principles guide our work. Because no two trademark cases are the same, we perform statistical analyses and utilize forensic accounting techniques as appropriate to generate damages models to align with case-specific issues. Our experts routinely provide analysis, opinions, and testimony in trademark disputes for both plaintiffs and defendants. Our team’s combined experience spans a spectrum of issues and industries, including advertising, computers and computer software, healthcare, apparel, medical devices, pharmaceutical, engineering, construction, retail, toys, beauty products, luxury goods, spirits, and beverages.
Richard Manning provided trial testimony that contributed to a decisive legal victory for biotech startup Inhibrx in a $460 million trade secrets case brought by I-Mab Biopharma in Delaware federal district court.
Under Dr. Guyer’s leadership, the new Engineering & Scientific Consulting practice will provide the critical research, analysis, and investigations expertise necessary to solve the challenging science, engineering, and regulatory questions behind why products fail and the implications for stakeholders.
The US Music Industries: Jobs & Benefits — 2024 Report
Robert Stoner and Jéssica Dutra have recently published The U.S. Music Industries: Jobs & Benefits—2024 Report for the Recording Industry Association of America where we measure the music industries’ economic impact nationwide, which overall contribute $212 billion to the GDP and account for 2.5 million jobs.